|
US7597886B2
(en)
|
1994-11-07 |
2009-10-06 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
|
US6225290B1
(en)
*
|
1996-09-19 |
2001-05-01 |
The Regents Of The University Of California |
Systemic gene therapy by intestinal cell transformation
|
|
US20030129750A1
(en)
*
|
1998-02-05 |
2003-07-10 |
Yitzhack Schwartz |
Homing of donor cells to a target zone in tissue using active therapeutics or substances
|
|
US7749215B1
(en)
*
|
1998-02-05 |
2010-07-06 |
Biosense, Inc. |
Intracardiac cell delivery and cell transplantation
|
|
US20030113303A1
(en)
*
|
1998-02-05 |
2003-06-19 |
Yitzhack Schwartz |
Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
|
|
AU3072799A
(en)
|
1998-03-19 |
1999-10-11 |
Human Genome Sciences, Inc. |
Cytokine receptor common gamma chain like
|
|
CN101818145A
(zh)
|
1998-03-20 |
2010-09-01 |
联邦科学和工业研究组织 |
控制基因表达
|
|
AUPP249298A0
(en)
*
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
JP2002513811A
(ja)
*
|
1998-05-06 |
2002-05-14 |
ファルマシア・アンド・アップジョン・カンパニー |
非−ヒト脊椎動物への、非−ヒト脊椎動物のペプチドホルモンまたはサイトカインをコードする裸のｄｎａまたは裸のｒｎａの導入
|
|
JPH11335269A
(ja)
|
1998-05-19 |
1999-12-07 |
Hisamitsu Pharmaceut Co Inc |
遺伝子関連医薬の経口投与固形製剤
|
|
CA2364417C
(en)
*
|
1999-02-19 |
2013-11-05 |
Matthew John During |
Peroral gene therapy of diabetes and obesity
|
|
EP1889914A1
(en)
*
|
1999-02-19 |
2008-02-20 |
Engene, Inc. |
Compositions for gene therapy of diabetes
|
|
AU3501700A
(en)
|
1999-02-26 |
2000-09-14 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
|
NZ514620A
(en)
*
|
1999-03-04 |
2004-04-30 |
Ppl Therapeutics Scotland Ltd |
Genetic modification of somatic cells and uses thereof
|
|
US6423885B1
(en)
|
1999-08-13 |
2002-07-23 |
Commonwealth Scientific And Industrial Research Organization (Csiro) |
Methods for obtaining modified phenotypes in plant cells
|
|
US6953658B2
(en)
|
2000-03-09 |
2005-10-11 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
|
|
WO2001068828A2
(en)
*
|
2000-03-13 |
2001-09-20 |
Engene, Inc. |
Compositions and methods for regulated protein expression in gut
|
|
ES2336887T5
(es)
|
2000-03-30 |
2019-03-06 |
Whitehead Inst Biomedical Res |
Mediadores de interferencia por ARN específicos de secuencias de ARN
|
|
EP2213743A1
(en)
|
2000-04-12 |
2010-08-04 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
GB0010630D0
(en)
*
|
2000-05-04 |
2000-06-21 |
Univ Wales Medicine |
Sequence
|
|
EP2431054A3
(en)
|
2000-06-15 |
2013-03-06 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor delta and epsilon
|
|
AU2001271621A1
(en)
|
2000-06-28 |
2002-01-08 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating colon cancer
|
|
CA2429814C
(en)
*
|
2000-12-01 |
2014-02-18 |
Thomas Tuschl |
Rna interference mediating small rna molecules
|
|
US20020151068A1
(en)
*
|
2001-01-03 |
2002-10-17 |
Board Of Regents, The University Of Texas System |
Compositions and methods for the diagnosis and treatment of organophosphate toxicity
|
|
WO2002064612A2
(en)
|
2001-02-09 |
2002-08-22 |
Human Genome Sciences, Inc. |
Human g-protein chemokine receptor (ccr5) hdgnr10
|
|
EP1383929A4
(en)
*
|
2001-04-04 |
2006-06-07 |
Neurome Inc |
GENES EXPRESSED IN DARMEPITHELIAL CELLS AND PEYERS 'PATCH M-CELLS
|
|
JP2004536579A
(ja)
|
2001-04-13 |
2004-12-09 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
血管内皮増殖因子２
|
|
AU2002311777A1
(en)
*
|
2001-04-17 |
2002-10-28 |
Genetix Pharmaceuticals, Inc. |
Method of treating arthritis using lentiviral vectors in gene therapy
|
|
EP1404713A4
(en)
*
|
2001-05-24 |
2004-09-22 |
Human Dna Technology Inc |
NEW KERATINOCYTE GROWTH FACTOR 2 ANALOG IN HAIR FOLLICULES
|
|
WO2003060066A2
(en)
*
|
2001-11-07 |
2003-07-24 |
Musc Foundation For Research Development |
Nucleic acid delivery and expression
|
|
US20030135195A1
(en)
*
|
2002-01-16 |
2003-07-17 |
Oscar Jimenez |
Highly lubricious hydrophilic coating utilizing dendrimers
|
|
AU2003215272B2
(en)
|
2002-02-14 |
2008-04-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enzyme treatment of foodstuffs for celiac sprue
|
|
EP1490520A4
(en)
*
|
2002-03-12 |
2006-06-07 |
Surface Logix Inc |
TEST APPARATUS ANALYZING THE ABSORPTION, METABOLISM, PERMEABILITY AND / OR TOXICITY OF A CANDIDATE COMPOUND
|
|
US7374930B2
(en)
*
|
2002-05-21 |
2008-05-20 |
Expression Genetics, Inc. |
GLP-1 gene delivery for the treatment of type 2 diabetes
|
|
US7977098B2
(en)
|
2002-05-31 |
2011-07-12 |
Children's Hospital Medical Center |
Antigenic binding patterns of norovirus to human histo-blood group antigens
|
|
WO2003101176A2
(en)
*
|
2002-05-31 |
2003-12-11 |
Children's Hospital Medical Center |
Method, composition and kit for antigenic binding of norwalk-like viruses
|
|
US20040016013A1
(en)
*
|
2002-07-18 |
2004-01-22 |
Gonzalo Hortelano |
Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent
|
|
US20040014704A1
(en)
*
|
2002-07-18 |
2004-01-22 |
Gonzalo Hortelano |
Oral administration of therapeutic agent coupled to transporting agent induces tolerance
|
|
US20040014698A1
(en)
*
|
2002-07-18 |
2004-01-22 |
Gonzalo Hortelano |
Oral administration of therapeutic agent coupled to transporting agent
|
|
GEP20084388B
(en)
*
|
2002-10-24 |
2008-06-10 |
Biogen Idec Inc |
High expression locus vector based on ferritin heavy chain gene locus
|
|
US20080026077A1
(en)
*
|
2002-11-12 |
2008-01-31 |
John Hilfinger |
Methods and compositions of gene delivery agents for systemic and local therapy
|
|
US20050026859A1
(en)
*
|
2002-11-12 |
2005-02-03 |
John Hilfinger |
Methods and compositions of gene delivery agents for systemic and local therapy
|
|
US20050169995A1
(en)
*
|
2003-10-03 |
2005-08-04 |
Kuo Calvin J. |
Modulation of gastrointestinal epithelium proliferation through the Wnt signaling pathway
|
|
US20050208032A1
(en)
*
|
2004-01-16 |
2005-09-22 |
Gonzalo Hortelano |
Oral administration of therapeutic agent coupled to transporting agent
|
|
AU2006326867A1
(en)
*
|
2005-12-20 |
2007-06-28 |
Cephalon Australia Pty Ltd |
Chimeric antibodies with part New World primate binding regions
|
|
CN102164618A
(zh)
*
|
2006-03-30 |
2011-08-24 |
恩根尼公司 |
用于体内转染肠细胞的非病毒组合物和方法
|
|
AU2008328584A1
(en)
*
|
2007-11-26 |
2009-06-04 |
Plant Bioscience Limited |
Novel polypeptides having endolysin activity and uses thereof
|
|
WO2009149191A2
(en)
|
2008-06-03 |
2009-12-10 |
University Of Rochester |
Methods of treating inflammatory intestinal disease and managing symptoms thereof
|
|
US20100068266A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo-modifiable multiple-release state final dosage form
|
|
US20100068233A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Modifiable dosage form
|
|
US20100068153A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo activatable final dosage form
|
|
US20100068235A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete LLC, a limited liability corporation of Deleware |
Individualizable dosage form
|
|
US20100068254A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Mahalaxmi Gita Bangera |
Modifying a medicament availability state of a final dosage form
|
|
US20100068275A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Personalizable dosage form
|
|
US20100069821A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo modifiable medicament release-sites final dosage form
|
|
US20100068152A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo modifiable particle or polymeric based final dosage form
|
|
US20100069887A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Multiple chamber ex vivo adjustable-release final dosage form
|
|
GB0908949D0
(en)
|
2009-05-26 |
2009-07-01 |
Plant Bioscience Ltd |
Novel polypeptides having endolysin activity and uses thereof
|
|
US8486421B2
(en)
|
2009-06-09 |
2013-07-16 |
Children's Hospital Medical Center |
Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use
|
|
US9321803B2
(en)
|
2013-07-12 |
2016-04-26 |
Children's Hospital Medical Center |
Compositions and methods for inhibiting norovirus infection
|
|
MA39819A
(fr)
|
2014-04-01 |
2017-02-08 |
Rubius Therapeutics Inc |
Méthodes et compositions d'immunomodulation
|
|
US20160160229A1
(en)
*
|
2014-12-09 |
2016-06-09 |
THC Farmaceuticals, Inc. |
Methods of producing antibody-rich cannabis and honeysuckle plants
|
|
EP3600397A4
(en)
|
2017-03-28 |
2021-01-27 |
Children's Hospital Medical Center |
NOROVIRUS PARTICLE VACCINES AND THEIR MANUFACTURING AND USE PROCEDURES
|
|
US20230023615A1
(en)
*
|
2019-12-13 |
2023-01-26 |
Dnalite Therapeutics, Inc. |
Compositions and methods for biological delivery vehicles
|
|
CN115515559B
(zh)
*
|
2019-12-20 |
2026-03-24 |
翻译生物公司 |
信使rna的直肠递送
|